過度糖化最終產物刺激C6神經膠瘤細胞表現誘導型一氧化氮合成酵素之訊息傳遞路徑

Signal Transduction of Advanced Glycosylation End Products(AGEs) Stimulated Inducible-Nitric Oxide Synthase Expression in C6 Glioma Cells

張夢筑(Chang Meng-Chu)

指導教授 ： 李宏謨

臺北醫學大學/醫學院/醫學檢驗生物技術學研究所/碩士(2001年)

摘要

在阿茲罕默氏症（Alzheimer’s disease）及其他許多退行性神經病變中，誘導型一氧化氮合成酵素（inducible nitric oxide synthase，簡稱iNOS）的活性扮演著重要的角色，而iNOS的蛋白表現會受到mitogen-activated protein kinase（MAPK）的調控。我們在實驗中，以過度糖化最終產物（BSA-AGEs）誘導C6神經膠瘤細胞（C6 glioma cells）iNOS的蛋白表現，發現p38 MAPK在其訊息傳遞過程扮演相當重要的角色。利用BSA-AGEs 刺激C6 glioma cells，不論是隨著劑量的增加或是反應時間的增加，iNOS的蛋白表現以及一氧化氮（NO）的產生都會隨之增加，而這種現象可以被基因轉錄抑制劑actinomycin D，基因轉譯抑制劑cyclohexamide，和iNOS抑制劑 Nw-nitro-L-arginine methyl easter（L-NAME）所抑制，由此可以推測iNOS的蛋白表現是由基因表現而來，而NO的增加則是由於iNOS的正調節作用（up-regulation）所致。另外，預先以tyrosine kinase抑制劑（genistein和tyrphostin）、Ras-farnesyl transferase抑制劑-II（FPT-II）、p38 MAPK抑制劑（SB203580）及MEK抑制劑（PD98059）等處理C6 glioma cells，都可以抑制由BSA-AGEs所刺激的iNOS表現及NO產生。BSA-AGEs可以促使C6神經膠瘤細胞p38 MAPK的活性增加，而此一現象會被genistein（20mM）、tyrphostin（30mM）、FPT inhibitor-II（20mM）和SB203580（10mM）所抑制，另外，BSA-AGEs也可以促使ERK的活性增加，相同地，也會被genistein（30mM）、FPT inhibitor-II（20mM）和PD98059（10mM）所抑制。綜合以上結果，我們的研究顯示，BSA-AGEs在C6 glioma cells中的訊息傳遞路徑是經由活化tyrosine kinase和Ras，導致p38 MAPK及ERK的活化，而進一步的促使iNOS表現而產生NO。

關鍵字

過度糖化最終產物 ； 誘導型一氧化氮合成酵素 ； C6神經膠瘤細胞 ； p38 MAP kinase ； ERK

並列摘要

Inducible nitric oxide synthase (iNOS) activity plays important roles in Alzheimer’s disease and other neurodegeneration diseases. The mitogen-activated protein kinase (MAPK) pathway is believed to function as an important mediator of iNOS expression. In the present study, we investigated the role of the p38 MAPK signaling pathway in advanced glycosylation end products (AGEs)-induced iNOS expression in C6 glioma cells. AGEs caused a dose-dependent increase of nitrite accumulation in C6 glioma cells. The AGEs-stimulated nitrite production from C6 glioma cells was inhibited by actinomycin D, cycloheximide, and the NO synthase inhibitor, Nw-nitro-L-arginine methyl ester (l-NAME), suggesting that the increase of AGEs-induced nitrite release is due to iNOS up-regulation. Consistently, treatment of C6 glioma cells with AGEs induced iNOS protein expression. The tyrosine kinase inhibitor (genistein & tyrphostin), the Ras-farnesyl transferase inhibitor (FPT inhibitor-II), the p38 MAPK inhibitor (SB203580), or the MEK inhibitor (PD98059) suppressed AGEs-induced iNOS expression and nitrite release from C6 glioma cells. AGEs activated p38 MAPK in C6 glioma cells, and this effect was blocked by genisteine (20 mM), tyrphostin (30 mM), FPT inhibitor-II (20 mM), and SB203580 (10 mM). AGEs also activated ERK in C6 glioma cells, and this effect was blocked by genisteine (30 mM), FPT inhibitor-II (30 mM), and PD98059 (10 mM). Taken together, our data suggest that AGEs may activate the pathways of tyrosine kinase and Ras to induce p38 MAPK and ERK activation, which in turn induces iNOS expression and NO production in C6 glioma cells.

並列關鍵字

AGEs ； iNOS ； C6 glioma cells ； p38 MAP kinase ； ERK

參考文獻

Bierhaus A., Chevion S., Chevion M., Hofmann M., Quehenberger P., Illmer T., Luther T., Berentshtein E., Tritschler H., Muller M., Wahl P., Ziegler R., Nawroth P.P., 1997a. Advanced glycation end product-induced activation of NF-kappa B is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 46:1481-1490.

Bierhaus A., Illmer T., Kasper M., Luther T., Quehenberger P., Tritschler H., Wahl P., Ziegler R., Muller M., Nawroth P.P., 1997b. Advanced glycation end products (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96:2262-2271.

Baker L., Dahlem S., Goldfarb S., Kern E.F., Stanley C.A., 1989. Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int. 35:1345-1350.

Bucala R., Makita Z., Kozchinsky T., Cerami A., Vlassara H., 1993. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. U.S.A. 90:6434-6438.

Cano E. and Mahadevan L.C., 1995. Parallel signal processing among mammalian MAPKs. Trend. Biochem. Sci. 20:117-122.